GlaxoSmithKline at the ACCI

Three floors of the six-storey building are occupied by GlaxoSmithKline, where it develops innovative medicines particularly for the treatment of neurological and psychiatric diseases including stroke, depression, schizophrenia and dementia.

For further information (including for health volunteers interested in volunteering for studies), contact GlaxoSmithKline
Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ
Tel: 0800 32 84 195 (Freephone) or 01223 296 001 (local call)
E-mail: uk_cru-cambridge@gsk.com
Offsite link: GlaxoSmithKline

 

Last updated: 14 November, 2007
Back to top